Literature DB >> 24004528

α7-Containing nicotinic acetylcholine receptors on interneurons of the basolateral amygdala and their role in the regulation of the network excitability.

Volodymyr I Pidoplichko1, Eric M Prager, Vassiliki Aroniadou-Anderjaska, Maria F M Braga.   

Abstract

The basolateral amygdala (BLA) plays a key role in fear-related learning and memory, in the modulation of cognitive functions, and in the overall regulation of emotional behavior. Pathophysiological alterations involving hyperexcitability in this brain region underlie anxiety and other emotional disorders as well as some forms of epilepsy. GABAergic interneurons exert a tight inhibitory control over the BLA network; understanding the mechanisms that regulate their activity is necessary for understanding physiological and disordered BLA functions. The BLA receives dense cholinergic input from the basal forebrain, affecting both normal functions and dysfunctions of the amygdala, but the mechanisms involved in the cholinergic regulation of inhibitory activity in the BLA are unclear. Using whole cell recordings in rat amygdala slices, here we demonstrate that the α(7)-containing nicotinic acetylcholine receptors (α(7)-nAChRs) are present on somatic or somatodendritic regions of BLA interneurons. These receptors are active in the basal state enhancing GABAergic inhibition, and their further, exogenous activation produces a transient but dramatic increase of spontaneous inhibitory postsynaptic currents in principal BLA neurons. In the absence of AMPA/kainate receptor antagonists, activation of α(7)-nAChRs in the BLA network increases both GABAergic and glutamatergic spontaneous currents in BLA principal cells, but the inhibitory currents are enhanced significantly more than the excitatory currents, reducing overall excitability. The anxiolytic effects of nicotine as well as the role of the α(7)-nAChRs in seizure activity involving the amygdala and in mental illnesses, such as schizophrenia and Alzheimer's disease, may be better understood in light of the present findings.

Entities:  

Keywords:  GABAA receptor; basolateral amygdala; inhibition; α7-nAChR

Mesh:

Substances:

Year:  2013        PMID: 24004528      PMCID: PMC3841870          DOI: 10.1152/jn.01030.2012

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  111 in total

Review 1.  Structural and functional diversity of native brain neuronal nicotinic receptors.

Authors:  Cecilia Gotti; Francesco Clementi; Alice Fornari; Annalisa Gaimarri; Stefania Guiducci; Irene Manfredi; Milena Moretti; Patrizia Pedrazzi; Luca Pucci; Michele Zoli
Journal:  Biochem Pharmacol       Date:  2009-05-27       Impact factor: 5.858

2.  alpha7 nicotinic acetylcholine receptors and modulation of gabaergic synaptic transmission in the hippocampus.

Authors:  M Alkondon; M F Braga; E F Pereira; A Maelicke; E X Albuquerque
Journal:  Eur J Pharmacol       Date:  2000-03-30       Impact factor: 4.432

Review 3.  Muscarinic acetylcholine receptors in the hippocampus, neocortex and amygdala: a review of immunocytochemical localization in relation to learning and memory.

Authors:  E A van der Zee; P G Luiten
Journal:  Prog Neurobiol       Date:  1999-08       Impact factor: 11.685

4.  Rat nicotinic ACh receptor alpha7 and beta2 subunits co-assemble to form functional heteromeric nicotinic receptor channels.

Authors:  Serguei S Khiroug; Patricia C Harkness; Patricia W Lamb; Sterling N Sudweeks; Leonard Khiroug; Neil S Millar; Jerrel L Yakel
Journal:  J Physiol       Date:  2002-04-15       Impact factor: 5.182

5.  Nicotinic mechanisms of memory: effects of acute local DHbetaE and MLA infusions in the basolateral amygdala.

Authors:  Nii A Addy; Aya Nakijama; Edward D Levin
Journal:  Brain Res Cogn Brain Res       Date:  2003-03

Review 6.  Strange feelings: do amygdala abnormalities dysregulate the emotional brain in schizophrenia?

Authors:  André Aleman; René S Kahn
Journal:  Prog Neurobiol       Date:  2005-12-13       Impact factor: 11.685

7.  Activation of functional α7-containing nAChRs in hippocampal CA1 pyramidal neurons by physiological levels of choline in the presence of PNU-120596.

Authors:  Bopanna I Kalappa; Alexander G Gusev; Victor V Uteshev
Journal:  PLoS One       Date:  2010-11-12       Impact factor: 3.240

8.  Amygdala volume in major depressive disorder: a meta-analysis of magnetic resonance imaging studies.

Authors:  J P Hamilton; M Siemer; I H Gotlib
Journal:  Mol Psychiatry       Date:  2008-05-27       Impact factor: 15.992

Review 9.  Mammalian nicotinic acetylcholine receptors: from structure to function.

Authors:  Edson X Albuquerque; Edna F R Pereira; Manickavasagom Alkondon; Scott W Rogers
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

10.  Anxiolytic effects of nicotine in a rodent test of approach-avoidance conflict.

Authors:  Ami Cohen; Robert W Young; Miguel A Velazquez; Mariya Groysman; Kavon Noorbehesht; Osnat M Ben-Shahar; Aaron Ettenberg
Journal:  Psychopharmacology (Berl)       Date:  2009-02-25       Impact factor: 4.530

View more
  26 in total

1.  Pathophysiological mechanisms underlying increased anxiety after soman exposure: reduced GABAergic inhibition in the basolateral amygdala.

Authors:  Eric M Prager; Volodymyr I Pidoplichko; Vassiliki Aroniadou-Anderjaska; James P Apland; Maria F M Braga
Journal:  Neurotoxicology       Date:  2014-08-20       Impact factor: 4.294

2.  α7 nicotinic receptor full agonist reverse basolateral amygdala hyperactivity and attenuation of dopaminergic neuron activity in rats exposed to chronic mild stress.

Authors:  Gilda A Neves; Anthony A Grace
Journal:  Eur Neuropsychopharmacol       Date:  2019-10-12       Impact factor: 4.600

3.  Loss of MeCP2 in cholinergic neurons causes part of RTT-like phenotypes via α7 receptor in hippocampus.

Authors:  Ying Zhang; Shu-Xia Cao; Peng Sun; Hai-Yang He; Ci-Hang Yang; Xiao-Juan Chen; Chen-Jie Shen; Xiao-Dong Wang; Zhong Chen; Darwin K Berg; Shumin Duan; Xiao-Ming Li
Journal:  Cell Res       Date:  2016-04-22       Impact factor: 25.617

Review 4.  Mood and anxiety regulation by nicotinic acetylcholine receptors: A potential pathway to modulate aggression and related behavioral states.

Authors:  Marina R Picciotto; Alan S Lewis; Gerrit I van Schalkwyk; Yann S Mineur
Journal:  Neuropharmacology       Date:  2015-01-09       Impact factor: 5.250

5.  Multiple Nicotinic Acetylcholine Receptor Subtypes in the Mouse Amygdala Regulate Affective Behaviors and Response to Social Stress.

Authors:  Yann S Mineur; Gianna M Fote; Sam Blakeman; Emma L M Cahuzac; Sylvia A Newbold; Marina R Picciotto
Journal:  Neuropsychopharmacology       Date:  2015-10-16       Impact factor: 7.853

Review 6.  Amygdala-prefrontal interactions in (mal)adaptive learning.

Authors:  Ekaterina Likhtik; Rony Paz
Journal:  Trends Neurosci       Date:  2015-01-09       Impact factor: 13.837

7.  Cholinergic Signaling Controls Conditioned Fear Behaviors and Enhances Plasticity of Cortical-Amygdala Circuits.

Authors:  Li Jiang; Srikanya Kundu; James D Lederman; Gretchen Y López-Hernández; Elizabeth C Ballinger; Shaohua Wang; David A Talmage; Lorna W Role
Journal:  Neuron       Date:  2016-05-05       Impact factor: 17.173

8.  Alpha-Linolenic Acid Treatment Reduces the Contusion and Prevents the Development of Anxiety-Like Behavior Induced by a Mild Traumatic Brain Injury in Rats.

Authors:  Taiza H Figueiredo; Carolina L Harbert; Volodymyr Pidoplichko; Camila P Almeida-Suhett; Hongna Pan; Katia Rossetti; Maria F M Braga; Ann M Marini
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

9.  Presynaptic Regulation of Tonic Inhibition by Neuromodulatory Transmitters in the Basal Amygdala.

Authors:  S Meis; T Endres; T Munsch; V Lessmann
Journal:  Mol Neurobiol       Date:  2018-03-20       Impact factor: 5.590

10.  Methylomic analysis of salivary DNA in childhood ADHD identifies altered DNA methylation in VIPR2.

Authors:  Beth Wilmot; Rebecca Fry; Lisa Smeester; Erica D Musser; Jonathan Mill; Joel T Nigg
Journal:  J Child Psychol Psychiatry       Date:  2015-08-25       Impact factor: 8.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.